Trisura Specialty Insurance Co. moved Monday to dismiss a lawsuit brought by Trulieve Inc. (CSE: TRUL) (OTCQX: TCNNF), arguing that multiple policy exclusions clearly preclude coverage in a wrongful death case involving a Massachusetts facility worker. The motion, filed in Florida federal court and first reported by Law360, outlines four separate provisions …
U.S. marijuana companies completed fewer capital raises in 2024 than in the year prior, but raised a good bit more money overall with the funding that did materialize, suggesting that some investors may be warming back up to the cannabis space. That’s the macro takeaway from Viridian Capital Advisors’ latest …
The cannabis rescheduling saga hit a new snag, with a chance the policy change could be nixed altogether. A Drug Enforcement Administration judge on Monday canceled marijuana rescheduling hearings set to begin next week and put the process on hold for at least three months, giving pro-rescheduling groups time to …
Despite delays in cannabis legalization efforts in the U.S., Tilray (NASDAQ: TLRY) still has its eyes on that prize. The company’s CEO, Irwin Simon, told investors on the company’s earnings call that if the U.S. legalized medical marijuana, it would “represent an additional $250-million opportunity for Tilray.” He based that figure …